Regarding the European Commission’s proposed roadmap “Pharmaceutical Strategy: Timely patient access to affordable medicines”, this briefing document shares some considerations and recommendations based on MSF’s 20 years of experience ...

MSF is responding to the global COVID-19 pandemic, providing treatment and care for people with COVID-19, protecting people living in vulnerable conditions, and ensuring uninterrupted essential health services. Having universal access ...

This analysis of Gavi's Advance Market Commitment (AMC) for Pneumococcal Conjugate Vaccines (PCVs) takes a critical look at issues with the AMC model, which is being replicated for other vaccines.